Lutisone(Fluticasone Propionate)

Therapeutic Group: Skin

Presentation

Lutisone ointment: Each gram of Lutisone ointment contains Fluticasone Propionate BP 50 micrograms.

Description

Lutisone ointment contains Fluticasone Propionate, a synthetic trifluorinated corticosteroid, for topical dermatologic use. It has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Indications

Lutisone (Fluticasone Propionate) ointment is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage & Administration

Apply a thin film of Lutisone (Fluticasone Propionate) ointment to the affected skin areas twice daily. Rub in gently.

Side Effects

The adverse reactions of Fluticasone Propionate ointment are usually mild, self-limiting, and consist primarily of pruritus, burning, hypertrichosis, increased erythema, hives, irritation, and lightheadedness. Each of these events occurred individually in less than 1% of patients. The following additional local adverse reactions have been reported infrequently with Fluticasone Propionate ointment – dryness, folliculitis, acneiform, eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, and miliaria.

Precautions

Fluticasone Propionate ointment may cause local cutaneous adverse reactions. If irritation develops, Fluticasone Propionate ointment should be discontinued. Fluticasone Propionate ointment should not be used in the presence of preexisting skin atrophy and should not be used where infection is present at the treatment site. This should not be used in the treatment of rosacea and perioral dermatitis.

Use in Pregnancy & Lactation

Pregnancy: There are no adequate and well-controlled studies in pregnant women. Fluticasone Propionate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Lactation:
It is not known whether topical administration of Fluticasone Propionate could result in sufficient systemic absorption to produce detectable quantities in human milk. Because many drugs are excreted in human milk, caution should be exercised when Fluticasone Propionate ointment is administered to a lactating woman.

Pediatric use:
Safety and effectiveness in pediatric patients below 4 years of age have not been established.

Over Dose

Topically applied Fluticasone Propionate ointment can be absorbed in sufficient amounts to produce systemic effects.

Storage

Protect from light and moisture.
Store at a temperature not exceeding 30°C.

Commercial Pack

Lutisone ointment: Each tube contains 10 gm ointment.